Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome.

Merat S, Khalili S, Mostajabi P, Ghorbani A, Ansari R, Malekzadeh R.

Dig Dis Sci. 2010 May;55(5):1385-90. doi: 10.1007/s10620-009-0854-9. Epub 2009 Jun 9.

PMID:
19507027
[PubMed - indexed for MEDLINE]
2.

Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial.

Cappello G, Spezzaferro M, Grossi L, Manzoli L, Marzio L.

Dig Liver Dis. 2007 Jun;39(6):530-6. Epub 2007 Apr 8.

PMID:
17420159
[PubMed - indexed for MEDLINE]
3.

Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial.

Liu JH, Chen GH, Yeh HZ, Huang CK, Poon SK.

J Gastroenterol. 1997 Dec;32(6):765-8.

PMID:
9430014
[PubMed - indexed for MEDLINE]
4.

Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.

Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.

Aliment Pharmacol Ther. 2005 Feb 15;21(4):435-44.

PMID:
15709995
[PubMed - indexed for MEDLINE]
Free Article
5.

Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children.

Kline RM, Kline JJ, Di Palma J, Barbero GJ.

J Pediatr. 2001 Jan;138(1):125-8.

PMID:
11148527
[PubMed - indexed for MEDLINE]
6.

Efficacy of Peppermint oil in diarrhea predominant IBS - a double blind randomized placebo - controlled study.

Alam MS, Roy PK, Miah AR, Mollick SH, Khan MR, Mahmud MC, Khatun S.

Mymensingh Med J. 2013 Jan;22(1):27-30.

PMID:
23416804
[PubMed - indexed for MEDLINE]
7.

A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.

Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.

Gastroenterol Clin Biol. 2008 Feb;32(2):147-52. doi: 10.1016/j.gcb.2007.06.001. Epub 2008 Mar 4.

PMID:
18387426
[PubMed - indexed for MEDLINE]
Free Article
8.

Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.

Leung WK, Wu JC, Liang SM, Chan LS, Chan FK, Xie H, Fung SS, Hui AJ, Wong VW, Che CT, Sung JJ.

Am J Gastroenterol. 2006 Jul;101(7):1574-80.

PMID:
16863563
[PubMed - indexed for MEDLINE]
9.

A double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome.

Masand PS, Pae CU, Krulewicz S, Peindl K, Mannelli P, Varia IM, Patkar AA.

Psychosomatics. 2009 Jan-Feb;50(1):78-86. doi: 10.1176/appi.psy.50.1.78.

PMID:
19213976
[PubMed - indexed for MEDLINE]
10.

Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: a randomized, placebo-controlled, double-blind clinical trial.

Brinkhaus B, Hentschel C, Von Keudell C, Schindler G, Lindner M, Stützer H, Kohnen R, Willich SN, Lehmacher W, Hahn EG.

Scand J Gastroenterol. 2005 Aug;40(8):936-43.

PMID:
16173134
[PubMed - indexed for MEDLINE]
11.

Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome--a randomized, double-blind, placebo-controlled study.

Wittmann T, Paradowski L, Ducrotté P, Bueno L, Andro Delestrain MC.

Aliment Pharmacol Ther. 2010 Mar;31(6):615-24. doi: 10.1111/j.1365-2036.2009.04216.x. Epub 2009 Dec 10.

PMID:
20003095
[PubMed - indexed for MEDLINE]
12.

Childhood abuse and treatment response in patients with irritable bowel syndrome: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release.

Han C, Masand PS, Krulewicz S, Peindl K, Mannelli P, Varia IM, Pae CU, Patkar AA.

J Clin Pharm Ther. 2009 Feb;34(1):79-88. doi: 10.1111/j.1365-2710.2008.00975.x.

PMID:
19125906
[PubMed - indexed for MEDLINE]
13.

[Dinggui Oil Capsule in treating irritable bowel syndrome with stagnation of qi and cold: a prospective, multi-center, randomized, placebo-controlled, double-blind trial].

Zhang RM, Wang L, Yang XN, Xia Q, Jiang MD, Fan ZJ, Zhang FX, Zhang HR, Yu Z, Li TQ.

Zhong Xi Yi Jie He Xue Bao. 2007 Jul;5(4):392-7. Chinese.

PMID:
17631801
[PubMed - indexed for MEDLINE]
Free Article
14.

Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.

Rahimi R, Nikfar S, Abdollahi M.

Clin Ther. 2008 May;30(5):884-901. doi: 10.1016/j.clinthera.2008.05.002.

PMID:
18555935
[PubMed - indexed for MEDLINE]
15.

Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome.

Drossman DA, Danilewitz M, Naesdal J, Hwang C, Adler J, Silberg DG.

Am J Gastroenterol. 2008 Oct;103(10):2562-9. doi: 10.1111/j.1572-0241.2008.02115.x. Epub 2008 Sep 4.

PMID:
18775020
[PubMed - indexed for MEDLINE]
16.

Octatropine methyl bromide and diazepam combination (Valpinax) in patients with irritable bowel syndrome: a multicentre, randomized, placebo-controlled trial.

Pace F, Maurano A, Ciacci C, Savarino V, Attili A, Iaquinto G, Magni E, Porro GB.

Eur Rev Med Pharmacol Sci. 2010 Mar;14(3):155-62.

PMID:
20391952
[PubMed - indexed for MEDLINE]
17.

Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome.

Chang FY, Lu CL, Chen CY, Luo JC.

J Gastroenterol Hepatol. 2007 Dec;22(12):2266-72. Epub 2007 Jun 7.

PMID:
17559369
[PubMed - indexed for MEDLINE]
18.

A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.

Chang L, Ameen VZ, Dukes GE, McSorley DJ, Carter EG, Mayer EA.

Am J Gastroenterol. 2005 Jan;100(1):115-23.

PMID:
15654790
[PubMed - indexed for MEDLINE]
19.

VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study.

Guandalini S, Magazzù G, Chiaro A, La Balestra V, Di Nardo G, Gopalan S, Sibal A, Romano C, Canani RB, Lionetti P, Setty M.

J Pediatr Gastroenterol Nutr. 2010 Jul;51(1):24-30. doi: 10.1097/MPG.0b013e3181ca4d95.

PMID:
20453678
[PubMed - indexed for MEDLINE]
20.

A double-blind crossover comparison study of the safety and efficacy of mebeverine with mebeverine sustained release in the treatment of irritable bowel syndrome.

Van Outryve M, Mayeur S, Meeus MA, Rosillon D, Hendrickx B, Ceuppens M.

J Clin Pharm Ther. 1995 Oct;20(5):277-82.

PMID:
8576295
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk